Emergent Biosolutions EBS Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's capital investments accrued but not yet paid?
- Emergent Biosolutions (EBS) reported capital investments accrued but not yet paid of $1M in Q1 2026.
- How has Emergent Biosolutions's capital investments accrued but not yet paid changed year-over-year?
- Emergent Biosolutions's capital investments accrued but not yet paid decreased by 33.3% year-over-year, from $1.5M to $1M.